No Data
CSPC Innovation Pharmaceutical Co., Ltd.'s (SZSE:300765) Popularity With Investors Is Clear
Express News | CSPC Innovation Says to Buy Stake in Biopharmaceutical Firm in a Deal to Be Settled by New Shares Issue, Cash
CSPC PHARMA (01093): CSPC Innovation (300765.SZ) expects a net profit attributable to parent company of 45 million to -66 million yuan in 2024, a year-on-year decrease of 84.81%–89.64%.
CSPC PHARMA (01093) announced that CSPC Innovation (300765.SZ) is expected to have a net profit attributable to the listed company in 2024...
New Novus: 2024 performance forecast
Could The Market Be Wrong About CSPC Innovation Pharmaceutical Co., Ltd. (SZSE:300765) Given Its Attractive Financial Prospects?
CSPC Innovation Pharmaceutical (300765.SZ) subsidiary Giant Stone Biotech SYS6010 drug has been included in the list of breakthrough therapy products.
CSPC Innovation Pharmaceutical (stock code 300765.SZ) announced that its subsidiary CSPC Pharma's Jusheng Bio-Pharmaceutical Co., Ltd. (referred to as ...